Plegridy Satisfaction Study in Participants
Launched by BIOGEN · Oct 23, 2015
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Subjects diagnosed with Relapsing Remitting MS according to 2010 McDonald criteria.
- • Subjects with EDSS score between 0.0 and 5.0 at baseline.
- Key Exclusion Criteria:
- • Pregnancy or breast-feeding.
- • Have any contra-indications to treatment with Peg-IFN-beta 1a according to the Summary of Product Characteristics.
- • NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Trial Officials
Medical Director
Study Director
Biogen
About Biogen
Biogen is a leading biotechnology company dedicated to discovering, developing, and delivering innovative therapies for neurological and neurodegenerative diseases. With a strong focus on research and development, Biogen leverages advanced science and cutting-edge technology to address the unmet needs of patients suffering from conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy. The company is committed to advancing the understanding of the underlying biology of these diseases and is actively engaged in clinical trials to evaluate new treatment options, aiming to improve patient outcomes and enhance quality of life. With a global presence and a robust pipeline of therapies, Biogen is at the forefront of innovation in the biopharmaceutical industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Genova, , Italy
Milano, , Italy
Napoli, , Italy
Torino, , Italy
Bari, , Italy
Arezzo, , Italy
Pavia, , Italy
Roma, , Italy
Orbassano, , Italy
Cefalù, , Italy
Fidenza, , Italy
Gallarate, , Italy
Messina, , Italy
Roma, , Italy
Modena, , Italy
Chieti, , Italy
Pozzilli, , Italy
Cagliari, , Italy
L'aquila, , Italy
Como, , Italy
Foligno, , Italy
Mondovì, , Italy
Ozieri, , Italy
Palermo, , Italy
Pietra Ligure, , Italy
Reggio Calabria, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
